Jade Biosciences Inc
(JBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 27,401 | 27,778 | 3,387 | 8,848 | 14,965 |
| Operating Income | -27,401 | -27,778 | -3,387 | -8,848 | -14,965 |
| Other Income | 2,226 | -4,356 | 869 | 3,513 | -1,312 |
| Pre-tax Income | -25,175 | -32,134 | -2,518 | -5,335 | -16,277 |
| Net Income Continuous | -25,175 | -32,134 | -2,518 | -5,390 | -16,277 |
| Net Income | $-25,175 | $-32,134 | $-2,518 | $-5,390 | $-16,277 |
| EPS Basic Total Ops | -0.48 | -0.86 | -3.16 | -21.16 | -5.16 |
| EPS Basic Continuous Ops | -0.64 | -1.13 | -3.05 | -20.82 | -5.16 |
| EPS Diluted Total Ops | -0.48 | -0.86 | -3.16 | -21.16 | -5.16 |
| EPS Diluted Continuous Ops | -0.64 | -1.13 | -3.05 | -20.82 | -5.16 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.86 | -3.16 | -6.67 | -19.65 |
| EBITDA(a) | $-27,563 | $-27,552 | $-3,608 | $-8,848 | $-14,965 |